ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,242.97
      -0.65%
      US Tech 100
      17,980.72
      -0.26%
      Dow Jones
      38,279.88
      -1.05%
      Brent Oil
      78.355
      -3.03%
      Bitcoin
      68,962.52
      1.79%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BioNexus Gene Lab Corporation (BGLC)

      7. BioNexus Gene Lab Corporation (BGLC) News

      BGLC

      BioNexus Gene Lab (BGLC)

      BioNexus Gene Lab Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BGLC
      DateTimeSourceHeadlineSymbolCompany
      05/31/20243:47PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
      05/31/20243:46PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
      05/31/20243:46PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
      05/31/20243:45PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
      05/31/20243:45PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
      05/09/202412:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
      04/18/20242:52PMGlobeNewswire Inc.BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareNASDAQ:BGLCBioNexus Gene Lab Corporation
      01/26/20244:05PMEdgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:BGLCBioNexus Gene Lab Corporation
      01/23/20247:55AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BGLCBioNexus Gene Lab Corporation
      11/03/202310:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
      09/07/202311:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
      07/24/20235:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
      07/24/202311:30AMGlobeNewswire Inc.BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital MarketNASDAQ:BGLCBioNexus Gene Lab Corporation
      07/20/20231:29PMGlobeNewswire Inc.BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital MarketNASDAQ:BGLCBioNexus Gene Lab Corporation
       Showing the most relevant articles for your search:NASDAQ:BGLC